HCA SVP exercises rights, adjusts share holdings

HCA Healthcare SVP & Controller Christopher F. Wyatt reported equity transactions involving company stock.

Rhea-AI Filing Summary

HCA Healthcare SVP & Controller Christopher F. Wyatt reported equity transactions involving company stock. On February 5, 2026, he exercised 10,670 Stock Appreciation Rights at an exercise price of $139.06, receiving the same number of HCA common shares and bringing his direct holdings to 51,737 shares.

On the same date, a separate transaction coded "F" disposed of 5,674 common shares at a reported price of $513.76 per share, leaving Wyatt with 46,063 HCA common shares held directly. The underlying stock appreciation rights, which vested in four equal annual installments beginning January 30, 2020, are now fully exercised.

Insider Trade Summary

10,670 shares exercised/converted

Exercise 3 txns

Insider Wyatt Christopher F.

Role SVP & Controller

Type	Security	Shares	Price	Value
Exercise	Stock Appreciation Right	10,670	$0.00	$0.00
Exercise	Common Stock	10,670	$139.06	$1.48M
Exercise Price or Tax Liability	Common Stock	5,674	$513.76	$2.92M

Holdings After Transaction: Stock Appreciation Right — 0 contracts (Direct); Common Stock — 46,063 shares (Direct)

Footnotes (1)

1. F1. The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HCA (HCA) report for Christopher F. Wyatt?

HCA reported that SVP & Controller Christopher F. Wyatt exercised 10,670 Stock Appreciation Rights on February 5, 2026, converting them into common shares, and also disposed of 5,674 common shares in a separate transaction coded "F" on the same date.

How many HCA (HCA) shares does Christopher F. Wyatt own after this Form 4?

After the reported transactions, Christopher F. Wyatt directly owns 46,063 shares of HCA common stock. This reflects exercising 10,670 Stock Appreciation Rights and a subsequent disposition of 5,674 shares, as disclosed in the Form 4 insider filing.

What derivative securities did HCA (HCA) executive Wyatt exercise?

Wyatt exercised 10,670 Stock Appreciation Rights with an exercise price of $139.06 per right on February 5, 2026. These rights were linked to HCA common stock and were fully converted into 10,670 shares, leaving him with no remaining Stock Appreciation Rights.

What does the transaction code "M" mean in the HCA (HCA) Form 4?

In this Form 4, transaction code "M" is used for the exercise of 10,670 Stock Appreciation Rights into HCA common stock at $139.06 per share. It indicates a derivative security was converted into underlying common shares on the reported date.

What is the significance of the "F" transaction on HCA (HCA) shares?

The Form 4 shows a transaction coded "F" where 5,674 common shares of HCA were disposed of at a reported price of $513.76 per share. This reduced Christopher F. Wyatt’s direct holdings to 46,063 shares following the transactions.

When did the exercised HCA (HCA) Stock Appreciation Rights originally vest?

The disclosed Stock Appreciation Rights vested in four equal annual installments beginning on January 30, 2020. By the February 5, 2026 transaction date, all 10,670 rights were fully vested and subsequently exercised into HCA common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 06:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wyatt Christopher F.

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Controller

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		M		10,670	A	$139.06	51,737	D
Common Stock	02/05/2026		F		5,674	D	$513.76	46,063	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$139.06	02/05/2026		M			10,670	(1)	01/30/2029	Common Stock	10,670	$0.00	0	D

Explanation of Responses:

1. The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

	/s/ Kevin A. Ball, Attorney-in-Fact	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.